Scribe Therapeutics Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $2,233 | $17,125 |
Net Income | -17,347 | -3,425 |
Net Change In Cash | 2,233 | 17,125 |
Free Cash Flow | -7,572 | -14,112 |
Cash | 20,381 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $51,174 | $27,413 |
Net Income | -21,808 | -47,786 |
Net Change In Cash | 51,174 | 27,413 |
Free Cash Flow | -46,484 | -46,584 |
Cash | 12,796 | 12,602 |